A recent survey of nearly 1,000 employers, reported by the Wall Street Journal and covered by NORML, found that about half no longer screen job applicants for cannabis before hiring. The reason employers gave most often wasn’t a philosophical awakening about bodily autonomy — it was simpler and more honest than that: they wanted a bigger applicant pool. Turns out that when you disqualify a huge swath of otherwise-qualified candidates over something with zero bearing on job performance, you shrink your own hiring options. Who knew.